That is my understanding from talking to the mgt team. That is they can identify specific cells, target those specific cells and deliver a toxin using EET to 'kill' only the appropriate parts without affecting any of the surrounding cells or tissues.
Compared to the current efficacy and approach that sounds like a godsend to most cancer patients and could truly change the way cancer is treated around the world. At a stretch you could almost say it's getting as close to a cure as you can get without actually reversing or permanently removing the affliction.
I wonder what that could be worth on the open market?
...and then you start thinking about the other applications such as arthritis, alzheimers, etc... the mind boggles.
BUT, where I get concerned is that no external party has yet signed up to take it on-board as part of their program. Why not? Is there something we're all missing?
- Forums
- ASX - By Stock
- PYC
- phenomica
phenomica, page-3
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
|
|||||
Last
12.0¢ |
Change
-0.010(7.69%) |
Mkt cap ! $559.9M |
Open | High | Low | Value | Volume |
13.0¢ | 13.0¢ | 11.5¢ | $308.5K | 2.533M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 358350 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 371822 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 317789 | 0.115 |
11 | 637126 | 0.110 |
10 | 1183875 | 0.105 |
13 | 2325475 | 0.100 |
3 | 113721 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 371822 | 1 |
0.125 | 217835 | 3 |
0.130 | 619798 | 7 |
0.135 | 100000 | 1 |
0.140 | 721230 | 7 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |